Amedisys, Inc. (NASDAQ:AMED) Short Interest Up 7.1% in January

Amedisys, Inc. (NASDAQ:AMED - Get Free Report) saw a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 2,550,000 shares, an increase of 7.1% from the January 15th total of 2,380,000 shares. Currently, 8.0% of the company's stock are short sold. Based on an average daily volume of 525,800 shares, the short-interest ratio is presently 4.8 days.

Analysts Set New Price Targets

Separately, Stephens reaffirmed an "equal weight" rating and issued a $101.00 target price on shares of Amedisys in a research report on Wednesday, February 12th. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $100.75.

Institutional Trading of Amedisys

Several large investors have recently made changes to their positions in AMED. Blue Trust Inc. boosted its stake in shares of Amedisys by 55.1% during the 4th quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock worth $34,000 after acquiring an additional 124 shares in the last quarter. HBW Advisory Services LLC bought a new stake in shares of Amedisys during the 4th quarter worth about $38,000. Versant Capital Management Inc boosted its stake in shares of Amedisys by 68.5% during the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider's stock worth $41,000 after acquiring an additional 183 shares in the last quarter. Johnson Financial Group Inc. bought a new stake in Amedisys during the 4th quarter valued at approximately $55,000. Finally, KBC Group NV bought a new stake in Amedisys during the 3rd quarter valued at approximately $63,000. Institutional investors own 94.36% of the company's stock.

Amedisys Stock Down 1.5 %

Shares of AMED traded down $1.42 during trading hours on Thursday, hitting $91.20. 959,481 shares of the company were exchanged, compared to its average volume of 291,990. The company has a market cap of $2.99 billion, a PE ratio of 36.19, a PEG ratio of 1.83 and a beta of 0.73. The firm's 50 day moving average is $90.64 and its 200-day moving average is $93.48. Amedisys has a 52 week low of $82.15 and a 52 week high of $98.95. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.